Clinical Trial Update: Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot Study [Phase 2]

View source ↗

Summary

Clinical trial update describing a randomized, double-blind Phase 2 pilot study evaluating low-dose albumin solution for spontaneous bacterial peritonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Albumin solution (human serum albumin)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Renal Impairment, All Cause Mortality | Phase 2 | Status: UNKNOWN